|
1
|
McLean MH and El-Omar EM: Genetics of
gastric cancer. Nat Rev Gastroenterol Hepatol. 11:664–674. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rahman R, Asombang AW and Ibdah JA:
Characteristics of gastric cancer in Asia. World J Gastroenterol.
20:4483–4490. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Acton S, Rigotti A, Landschulz KT, Xu S,
Hobbs HH and Krieger M: Identification of scavenger receptor SR-BI
as a high density lipoprotein receptor. Science. 271:518–520. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Guo L, Song Z, Li M, Wu Q, Wang D, Feng H,
Bernard P, Daugherty A, Huang B and Li XA: Scavenger receptor BI
protects against septic death through its role in modulating
inflammatory response. J Biol Chem. 284:19826–19834. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li Y, Kakinami C, Li Q, Yang B and Li H:
Human apolipoprotein A-I is associated with dengue virus and
enhances virus infection through SR-BI. PLoS One. 8:e703902013.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Feng H, Guo L, Wang D, Gao H, Hou G, Zheng
Z, Ai J, Foreman O, Daugherty A and Li XA: Deficiency of scavenger
receptor BI leads to impaired lymphocyte homeostasis and autoimmune
disorders in mice. Arterioscler Thromb Vasc Biol. 31:2543–2551.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cao WM, Murao K, Imachi H, Yu X, Abe H,
Yamauchi A, Niimi M, Miyauchi A, Wong NC and Ishida T: A mutant
high-density lipoprotein receptor inhibits proliferation of human
breast cancer cells. Cancer Res. 64:1515–1521. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Danilo C, Gutierrez-Pajares JL, Mainieri
MA, Mercier I, Lisanti MP and Frank PG: Scavenger receptor class B
type I regulates cellular cholesterol metabolism and cell signaling
associated with breast cancer development. Breast Cancer Res.
15:R872013. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wadsack C, Hirschmugl B, Hammer A,
Levak-Frank S, Kozarsky KF, Sattler W and Malle E: Scavenger
receptor class B, type I on non-malignant and malignant human
epithelial cells mediates cholesteryl ester-uptake from high
density lipoproteins. Int J Biochem Cell Biol. 35:441–454. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Leon CG, Locke JA, Adomat HH, Etinger SL,
Twiddy AL, Neumann RD, Nelson CC, Guns ES and Wasan KM: Alterations
in cholesterol regulation contribute to the production of
intratumoral androgens during progression to castration-resistant
prostate cancer in a mouse xenograft model. Prostate. 70:390–400.
2010.PubMed/NCBI
|
|
11
|
Shahzad MM, Mangala LS, Han HD, Lu C,
Bottsford-Miller J, Nishimura M, Mora EM, Lee JW, Stone RL, Pecot
CV, et al: Targeted delivery of small interfering RNA using
reconstituted high-density lipoprotein nanoparticles. Neoplasia.
13:309–319. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zheng Y, Liu Y, Jin H, Pan S, Qian Y,
Huang C, Zeng Y, Luo Q, Zeng M and Zhang Z: Scavenger receptor B1
is a potential biomarker of human nasopharyngeal carcinoma and its
growth is inhibited by HDL-mimetic nanoparticles. Theranostics.
3:477–486. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lobo MV, Huerta L, Ruiz-Velasco N,
Teixeiro E, de la Cueva P, Celdrán A, Martín-Hidalgo A, Vega MA and
Bragado R: Localization of the lipid receptors CD36 and CLA-1/SR-BI
in the human gastrointestinal tract: Towards the identification of
receptors mediating the intestinal absorption of dietary lipids. J
Histochem Cytochem. 49:1253–1260. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Berlth F, Bollschweiler E, Drebber U,
Hoelscher AH and Moenig S: Pathohistological classification systems
in gastric cancer: Diagnostic relevance and prognostic value. World
J Gastroenterol. 20:5679–5684. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yu H and Xin Y: Down-regulated expressions
of PPARγ and its coactivator PGC-1 are related to gastric
carcinogenesis and Lauren's classification in gastric carcinoma.
Chin J Cancer Res. 25:704–714. 2013.PubMed/NCBI
|
|
16
|
Kwon OK, Kim SW, Chae HD, Ryu SW, Chung
HY, Kim SW, Lee WK and Yu W: Validation of the 7th AJCC/UICC
staging system for gastric cancer and a proposal for a new TNM
system based on a prognostic score: A retrospective multicenter
study. Ann Surg Treat Res. 91:295–302. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bogan RL and Hennebold JD: The reverse
cholesterol transport system as a potential mediator of luteolysis
in the primate corpus luteum. Reproduction. 139:163–176. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Remmele W and Stegner HE: Recommendation
for uniform definition of an immunoreactive score (IRS) for
immunohistochemical estrogen receptor detection (ER-ICA) in breast
cancer tissue. Pathologe. 8:138–140. 1987.(In German). PubMed/NCBI
|
|
19
|
Hu B, El Hajj N, Sittler S, Lammert N,
Barnes R and Meloni-Ehrig A: Gastric cancer: Classification,
histology and application of molecular pathology. J Gastrointest
Oncol. 3:251–261. 2012.PubMed/NCBI
|
|
20
|
Ghandur-Mnaymneh L, Paz J, Roldan E and
Cassady J: Dysplasia of nonmetaplastic gastric mucosa. A proposal
for its classification and its possible relationship to
diffuse-type gastric carcinoma. Am J Surg Pathol. 12:96–114. 1988.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cristescu R, Lee J, Nebozhyn M, Kim KM,
Ting JC, Wong SS, Liu J, Yue YG, Wang J, Yu K, et al: Molecular
analysis of gastric cancer identifies subtypes associated with
distinct clinical outcomes. Nat Med. 21:449–456. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cancer Genome Atlas Research Network, .
Comprehensive molecular characterization of gastric adenocarcinoma.
Nature. 513:202–209. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Shah MA, Khanin R, Tang L, Janjigian YY,
Klimstra DS, Gerdes H and Kelsen DP: Molecular classification of
gastric cancer: A new paradigm. Clin Cancer Res. 17:2693–2701.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Shen H, Newmann AS, Hu Z, Zhang Z, Xu Y,
Wang L, Hu X, Guo J, Wang X and Wei Q: Methylenetetrahydrofolate
reductase polymorphisms/haplotypes and risk of gastric cancer: A
case-control analysis in China. Oncol Rep. 13:355–360.
2005.PubMed/NCBI
|
|
25
|
Guo E, Chen L, Xie Q, Chen J, Tang Z and
Wu Y: Serum HDL-C as a potential biomarker for nodal stages in
gastric cancer. Ann Surg Oncol. 14:2528–2534. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tamura T, Inagawa S, Hisakura K, Enomoto T
and Ohkohchi N: Evaluation of serum high-density lipoprotein
cholesterol levels as a prognostic factor in gastric cancer
patients. J Gastroenterol Hepatol. 27:1635–1640. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Caruso MG, Notarnicola M, Cavallini A and
Di Leo A: 3-Hydroxy-3-methylglutaryl coenzyme A reductase activity
and low-density lipoprotein receptor expression in diffuse-type and
intestinal-type human gastric cancer. J Gastroenterol. 37:504–508.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Barresi V, Giuffre G, Vitarelli E, Todaro
P and Tuccari G: Caveolin-1 immuno-expression in human gastric
cancer: Histopathogenetic hypotheses. Virchows Arch. 453:571–578.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Han J, Parsons M, Zhou X, Nicholson AC,
Gotto AM Jr and Hajjar DP: Functional interplay between the
macrophage scavenger receptor class B type I and pitavastatin
(NK-104). Circulation. 110:3472–3479. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhao SP, Wu ZH, Hong SC, Ye HJ and Wu J:
Effect of atorvastatin on SR-BI expression and HDL-induced
cholesterol efflux in adipocytes of hypercholesterolemic rabbits.
Clin Chim Acta. 365:119–124. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Tsuruoka H, Khovidhunkit W, Brown BE,
Fluhr JW, Elias PM and Feingold KR: Scavenger receptor class B type
I is expressed in cultured keratinocytes and epidermis. Regulation
in response to changes in cholesterol homeostasis and barrier
requirements. J Biol Chem. 277:2916–2922. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kimura T, Mogi C, Tomura H, Kuwabara A, Im
DS, Sato K, Kurose H, Murakami M and Okajima F: Induction of
scavenger receptor class B type I is critical for simvastatin
enhancement of high-density lipoprotein-induced anti-inflammatory
actions in endothelial cells. J Immunol. 181:7332–7340. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Mardones P, Pilon A, Bouly M, Duran D,
Nishimoto T, Arai H, Kozarsky KF, Altayo M, Miquel JF, Luc G, et
al: Fibrates down-regulate hepatic scavenger receptor class B type
I protein expression in mice. J Biol Chem. 278:7884–7890. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lan D and Silver DL: Fenofibrate induces a
novel degradation pathway for scavenger receptor B-I independent of
PDZK1. J Biol Chem. 280:23390–23396. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yuan B, Wu C, Wang X, Wang D, Liu H, Guo
L, Li XA, Han J and Feng H: High scavenger receptor class B type I
expression is related to tumor aggressiveness and poor prognosis in
breast cancer. Tumour Biol. 37:3581–3588. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Twiddy AL, Cox ME and Wasan KM: Knockdown
of scavenger receptor class B type I reduces prostate specific
antigen secretion and viability of prostate cancer cells. Prostate.
72:955–965. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Schörghofer D, Kinslechner K, Preitschopf
A, Schütz B, Röhrl C, Hengstschläger M, Stangl H and Mikula M: The
HDL receptor SR-BI is associated with human prostate cancer
progression and plays a possible role in establishing androgen
independence. Reprod Biol Endocrinol. 13:882015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kitadai Y, Sasaki A, Ito M, Tanaka S, Oue
N, Yasui W, Aihara M, Imagawa K, Haruma K and Chayama K:
Helicobacter pylori infection influences expression of genes
related to angiogenesis and invasion in human gastric carcinoma
cells. Biochem Biophys Res Commun. 311:809–814. 2003. View Article : Google Scholar : PubMed/NCBI
|
